Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
Hepatocellular carcinoma (HCC) is a well-known complication of genetic hemochromatosis (GH). However, the frequency of primary liver carcinoma (PLC) with biliary differentiation, such as cholangiocarcinoma (CC) and combined hepatocholangiocarcinoma (CHCC), in GH remains unclear We analyzed the histologic type of 20 PLCs occurring in the background of GH; all patients were homozygotic for the C282Y mutation. Ten were depleted of iron by successive phlebotomies, while the remaining 10 were untreated. Histologically, 13 cases were classified as HCC, 3 as CC, and 4 as CHCC. Immunohistochemical detection of Hep Par 1, cytokeratin 19 (CK19), and MUC1 supported this classification; PLC with biliary differentiation was immunoreactive for MUC1 in 86% (6/7) of cases and for CK19 in 100% (7/7) of cases. The nontumoral liver exhibited no cirrhosis or extensive fibrosis in 6 cases. Von Meyenburg complexes were present in 11 cases and intraparenchymal bile duct adenomas in 3. These data suggest that PLCs in patients with GH present a wide histologic spectrum, with tumors showing frequent biliary differentiation; may arise on a nonfibrotic or a cirrhotic liver; and often are associated with Von Meyenburg complexes and to a lesser extent with bile duct adenomas.
Morcos
M
M
Department of Pathology, Hôpital Beaujon, Clichy, France.
Dubois
S
S
Bralet
M P
MP
Belghiti
J
J
Degott
C
C
Terris
B
B
D002759:Adenoma, Bile Duct / Q000737:chemistry / Q000209:etiology / Q000235:genetics / Q000473:pathology; D001650:Bile Duct Neoplasms / Q000737:chemistry / Q000209:etiology / Q000235:genetics / Q000473:pathology; D001653:Bile Ducts, Intrahepatic / Q000473:pathology*; D014408:Biomarkers, Tumor / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000737:chemistry / Q000209:etiology / Q000235:genetics / Q000473:pathology*; D018281:Cholangiocarcinoma / Q000737:chemistry / Q000209:etiology / Q000235:genetics / Q000473:pathology; D006432:Hemochromatosis / Q000150:complications / Q000235:genetics / Q000473:pathology*; D006720:Homozygote; D006801:Humans; D007124:Immunoenzyme Techniques; D007633:Keratins / Q000032:analysis; D008113:Liver Neoplasms / Q000737:chemistry / Q000209:etiology / Q000235:genetics / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D018396:Mucin-1 / Q000032:analysis; D009154:Mutation
D014408:Biomarkers, Tumor; D018396:Mucin-1; D007633:Keratins